Clinical Guides
Sensory Neuropathy
An India-adapted, cause-first guide to recognising sensory neuropathy, testing selectively for diabetes and vitamin B12 deficiency, reviewing toxins and medicines, reducing falls and foot injury, and escalating urgent neurological presentations.
MedNext Academy | 12 min read
Sensory Neuropathy
An India-adapted, cause-first guide to recognising sensory neuropathy, testing selectively for diabetes and vitamin B12 deficiency, reviewing toxins and medicines, reducing falls and foot injury, and escalating urgent neurological presentations.
Summary
Sensory neuropathy is dysfunction of peripheral sensory nerves, causing symptoms such as burning pain, pins and needles, electric shocks, numbness, reduced vibration or impaired balance. It is a clinical syndrome, not a single diagnosis. Length-dependent neuropathy often begins symmetrically in the toes and feet and may later involve the hands, but non-length-dependent, focal, asymmetric, rapidly progressive or sensory-ataxic patterns suggest different causes and need careful review. Small-fibre symptoms can be severe while routine nerve-conduction studies are normal; a normal test does not invalidate a credible examination and history.
The safest approach is cause-first. Confirm the pattern, examine strength, reflexes, gait and autonomic features, and look for diabetes or prediabetes, vitamin B12 deficiency, alcohol exposure, renal or thyroid disease, paraproteinaemia, HIV, nutritional disease, inherited neuropathy, toxins and neurotoxic medicines. Testing should be guided by probability and local pathways rather than a large unfocused panel. Treatment includes correcting an identified cause, protecting insensitive feet, addressing sleep and function, and offering neuropathic-pain medicines when appropriate. This draft is an educational aid, not a diagnosis or prescription.
Before calling symptoms chronic, establish the tempo and the person’s safety. Ask whether they can feel a hot floor, recognise a shoe rubbing, climb stairs and walk in darkness. A symptom diary can record location, time, triggers, falls, sleep and medicine effects, but it should complement examination. Explain uncertainty honestly: some causes are reversible, some are controllable, and some require specialist testing. Avoid promising that a supplement, detoxification product or pain tablet will regenerate nerves. The first clinical task is preventing avoidable injury while the diagnostic pathway proceeds.
A good consultation ends with a shared next step: which cause is being checked first, how the feet will be protected today, what adverse medicine effects matter, and when results or progression will be reviewed. This reduces both therapeutic delay and unsafe self-medication.
How Common Is It?
Peripheral neuropathic symptoms are common in diabetes and increase with duration and poor metabolic control, but not every burning foot is diabetic neuropathy. Ageing, alcohol, nutritional deficiency, chemotherapy, renal disease, HIV and entrapment disorders contribute to the clinical workload. Prevalence figures vary because studies use different definitions, tests and populations; do not transplant a single Western estimate to Indian communities.
In India, undiagnosed diabetes, vegetarian diets with possible B12 deficiency, alcohol exposure, tuberculosis and its treatments, occupational chemical exposure and variable access to neurology or electrophysiology shape the differential. Cultural explanations and stigma may delay care. Ask what the person means by “weakness,” “numbness” or “burning” and what they can no longer do, rather than treating a symptom label as a diagnosis.
The burden is not only pain. Loss of protective sensation causes burns, pressure injury, unnoticed wounds and falls; sleep, driving, work and walking may be affected. A practical review records distribution, progression, falls, footwear, foot inspection and function. A stable mild pattern can be managed in primary care with follow-up, while rapid change, motor signs or systemic illness should shorten the pathway. Documenting function also helps distinguish a tolerable sensory symptom from a safety-threatening loss of protection and supports a meaningful treatment goal.
Risk Factors
Diabetes and impaired glucose regulation are important risks, but glycaemic status must be measured rather than assumed. Ask about duration, complications, glucose records and other vascular risks. Review diet, weight loss, gastrointestinal surgery, metformin or acid-suppressing drugs, alcohol and malabsorption when B12 deficiency is possible. Enquire about renal, thyroid, liver and autoimmune disease, malignancy, HIV risk, family history, recurrent attacks and exposure to chemotherapy, nitrous oxide, heavy metals, solvents or unregulated remedies.
Build a complete medication timeline. Neurotoxic chemotherapy, isoniazid, linezolid, nitrofurantoin, amiodarone and some antiretrovirals are examples in which specialist or product-information review may be needed; never stop an essential medicine abruptly without the prescriber. Pyridoxine-containing supplements can themselves cause sensory neuropathy at excessive or prolonged exposure. Ask about alcohol quantity without judgement.
Risk of harm rises with visual impairment, poor footwear, callus, foot deformity, renal failure, sedating medicines, orthostatic symptoms, frailty or a history of falls. Pregnancy, immunosuppression and cancer treatment alter urgency and treatment choices. A risk factor is a prompt to investigate, not proof of causation; temporal relation, examination and response to correction still matter.
Diagnosis
Diagnosis begins with pattern recognition and a neurological examination, followed by focused testing for treatable causes. Document a baseline sensory map and functional risk.
History
Clarify onset, tempo, distribution, symmetry, sensory quality, pain severity, nocturnal symptoms and progression. Ask about imbalance, falls, weakness, cramps, autonomic symptoms, bladder or bowel change, erectile dysfunction, postural dizziness and constitutional symptoms. Review diabetes, diet, alcohol, renal, thyroid, autoimmune, infectious and malignant history. Take a full medicine, supplement, chemotherapy and occupational exposure history, including timing and dose uncertainty. Ask about family members with high arches, walking difficulty or similar symptoms. Establish sleep, mood, work and walking impact, and the person’s goals.
Examination
Inspect skin, colour, temperature, hair, callus, fissures, ulcers, deformity and footwear. Test pinprick, temperature where available, vibration, joint position and light touch in a length-dependent comparison; map asymmetry. Check ankle and knee reflexes, power, tone, coordination, Romberg stance and gait. Examine pulses and pressure points because vascular disease and neuropathy may coexist. Look for cranial signs, sensory level, upper motor-neuron signs, autonomic hypotension and systemic clues. A painful allodynic foot may have little visible change; an insensitive foot can look normal despite danger.
Investigations
Baseline testing is often directed at glucose or HbA1c, full blood count, renal and liver function, thyroid function, vitamin B12 with a clarifying metabolite test when appropriate, and serum protein electrophoresis or immunofixation when a paraprotein is plausible. Add HIV, syphilis, coeliac, copper or autoimmune testing only when history or examination supports it. Nerve-conduction studies and EMG help classify large-fibre, axonal, demyelinating, focal or motor disease; refer for testing when atypical, progressive or diagnostically uncertain. Skin biopsy or autonomic testing is specialist work for suspected small-fibre disease. Do not delay urgent referral while collecting a long panel.
Differential Diagnosis
Diabetic distal symmetric polyneuropathy is common but remains a diagnosis of pattern plus exclusion of important alternatives. B12 deficiency can cause neuropathy with impaired position sense, gait disturbance, anaemia or cognitive features; neurological injury may become incomplete even after blood counts improve. Alcohol-related and nutritional neuropathies may coexist. Drug- or toxin-induced disease requires an exposure timeline, and a supplement history is essential because excess pyridoxine is a preventable cause.
Entrapment neuropathy, radiculopathy and plexopathy are usually focal or dermatomal rather than a symmetric stocking pattern. Spinal cord disease is suggested by a sensory level, brisk reflexes, sphincter symptoms or upper motor-neuron signs. Guillain–Barré syndrome and other inflammatory neuropathies can progress rapidly with weakness, areflexia or autonomic instability. Vasculitic, paraneoplastic, infectious and paraproteinaemic neuropathies may be painful, asymmetric, multifocal or rapidly progressive.
Consider erythromelalgia, restless legs, peripheral arterial disease, small-fibre disorders, functional symptoms and musculoskeletal pain when examination does not fit. Burning feet with normal large-fibre studies need a coherent reassessment, not dismissal. A sudden unilateral deficit, acute ataxia, cauda-equina symptoms or a rapidly ascending illness is an urgent neurological problem, not routine chronic neuropathy.
Management
Treat the cause where identified. Optimise diabetes collaboratively without promising that glucose normalisation will reverse established nerve injury; review B12 deficiency promptly and address malabsorption or the responsible medicine. Reduce alcohol, correct nutritional deficiency, and discuss toxic or neurotoxic exposures with the relevant prescriber or occupational service. Never discontinue insulin, antimicrobials, anticonvulsants or cancer therapy independently. Review at a defined interval with symptoms, examination and function rather than a single laboratory number.
Protect feet every day: inspect soles and between toes, wash and dry carefully, moisturise dry skin but not between toes, avoid walking barefoot and test bath water away from an insensitive foot. Use properly fitting footwear and avoid direct heat, hot-water bottles and chemical corn removers. A clinician or foot-care service should assess callus, deformity, ulcers, infection and pulses; diabetes may require a risk-stratified foot pathway. Balance training, strength work, vision correction and home hazard reduction can reduce falls.
For painful neuropathy, first discuss sleep, pacing, activity, psychological support and realistic goals. A clinician may consider an evidence-supported neuropathic-pain medicine according to comorbidity, renal function, interactions, pregnancy, local formulary and adverse effects. These drugs are not interchangeable, do not repair nerves and can cause dizziness, sedation or dependence-related harms. Start low and review only under a prescriber’s plan; avoid unsupported combinations and long-term opioid escalation.
Treat depression, anxiety and insomnia as clinical problems, and involve physiotherapy, podiatry, diabetes, pain or neurology services when function or safety is affected.
Prescribing Information
There is no single medicine that treats every sensory neuropathy. Prescribing follows the cause, phenotype, pain burden, renal and hepatic function, age, pregnancy status, interactions, falls risk and local Indian product information. Correct B12 deficiency with a clinician-selected preparation and route, while investigating why deficiency occurred; do not give folate alone when B12 deficiency has not been considered. Diabetes medicines are adjusted to the person’s overall plan, not to neuropathic pain alone.
For neuropathic pain, commonly used classes include a serotonin–noradrenaline reuptake inhibitor, a gabapentinoid or a tricyclic antidepressant in selected patients. Choice and dose require an individual prescription; renal impairment, glaucoma, urinary retention, arrhythmia, orthostatic hypotension, pregnancy, respiratory disease, substance-use history and concurrent sedatives may alter safety. Counsel about drowsiness, dizziness, driving, falls, mood change and the need for gradual tapering where appropriate. Do not imply that a named class is safe for everyone or provide a regimen without examination.
Topical lidocaine or capsaicin may suit selected localised pain under product guidance, but they do not treat numbness or the cause. Avoid routine opioids, unregulated “nerve tonics,” high-dose pyridoxine and polypharmacy. Review benefit using pain and function goals after an adequate trial; stop or change treatment when harms outweigh gains. Document indication, starting plan, safety-netting, interactions, monitoring and follow-up.
When to Refer
Refer to neurology for rapidly progressive symptoms, marked asymmetry, non-length-dependent or multifocal distribution, motor weakness, sensory ataxia, cranial involvement, prominent autonomic dysfunction, suspected inflammatory or inherited neuropathy, unexplained severe pain, abnormal upper motor-neuron signs or diagnostic uncertainty. Electrophysiology is often useful when the phenotype is atypical or progression continues.
Urgent or same-day assessment is required for new weakness with breathing or swallowing difficulty, rapidly ascending symptoms, acute severe ataxia, bowel or bladder dysfunction, a sensory level, severe autonomic instability, acute foot infection with systemic illness, or sudden focal neurological deficit. A painful swollen or discoloured foot, ulcer, spreading cellulitis, gangrene or suspected Charcot change requires urgent foot or vascular assessment.
Refer to diabetes or foot services for recurrent ulcers, high-risk diabetes, deformity, callus, poor vision or inability to inspect the feet. Consider haematology, infectious disease, oncology, toxicology, dietetics or pain services when testing identifies a paraprotein, infection, treatment toxicity, nutritional disorder or complex pain. Referral should coordinate care, not produce parallel unsupported prescriptions.
Red Flags
Red flags for acute neurological disease include hours-to-days onset, rapid progression, ascending numbness, new weakness, facial or bulbar symptoms, breathlessness, severe gait ataxia, urinary retention or incontinence, a sensory level, marked neck or back pain, fever, meningism or autonomic instability. These features need urgent assessment for spinal, inflammatory, infectious, vascular or toxic causes.
Foot emergencies include an ulcer, black or pale tissue, rapidly spreading redness, pus, fever, disproportionate pain, new warmth and swelling, suspected foreign body or inability to bear weight. Neuropathy can mask pain; visual inspection and palpation matter. Do not wait for routine blood tests when tissue is threatened.
Cancer, weight loss, night sweats, monoclonal protein, vasculitic rash, renal decline or recent neurotoxic exposure raise concern for systemic disease. Severe hypoglycaemia, intoxication, medication overdose or abrupt withdrawal also requires immediate care.
Safety red flags from medicines include new confusion, falls, suicidal thinking, severe sedation, breathing difficulty, allergic reaction or escalating unsupervised doses. A normal HbA1c, normal nerve-conduction study or absence of visible foot injury does not neutralise a concerning clinical pattern.
Indian Clinical Context
India’s clinical context makes a cause-first history particularly important. Screen for diabetes using current local practice, ask about vegetarian or restrictive diets and gastrointestinal disease when B12 deficiency is plausible, and review alcohol, occupational solvents, agricultural chemicals, unregulated supplements and traditional remedies without judgement. Isoniazid, linezolid, chemotherapy and other medicines may contribute in selected patients; the responsible prescriber should coordinate any change.
Foot-care advice must fit footwear, household floors, work demands, climate and access to podiatry. A person who walks barefoot for cultural, occupational or financial reasons needs practical harm reduction and affordable protective options rather than blame. Inspect feet in every appropriate diabetes review, teach family-supported inspection when vision or mobility is limited, and provide a local return pathway for wounds. Do not promise that a branded “nerve tonic” or supplement will restore sensation; excess pyridoxine may harm.
Access to EMG, neurology, B12 metabolites and specialist pain care varies between districts. Use the highest-yield available tests, document uncertainty, and refer when the pattern is atypical or dangerous. Check current Indian product information, National Programme guidance and institutional formulary before prescribing. Explain results in the patient’s language and address driving, work, sleep, stigma and cost. This guide supports NMC learning and safe counselling; it does not replace a clinician or local emergency service.
NMC Competency Mapping
This topic supports supervised NMC-aligned learning in Medicine, Neurology, Pharmacology, Pathology, Community Medicine, Family Medicine and AETCOM. Learners should define a sensory neuropathy pattern, distinguish large- and small-fibre symptoms, examine sensation, reflexes, power, gait, pulses and skin, and identify the difference between a chronic length-dependent syndrome and an urgent progressive neurological illness.
A diagnostic station should require a cause-first differential including diabetes, B12 deficiency, alcohol, toxins, drugs, renal or thyroid disease, paraproteinaemia, infection, inflammatory neuropathy and spinal disease. Learners should order focused tests, interpret limitations of nerve-conduction studies and avoid treating a risk factor as proof.
A prescribing station should test medication and supplement review, renal and falls-risk checks, counselling about sedation and driving, and documentation of review goals. A foot station should demonstrate inspection, protective advice, ulcer escalation and culturally respectful communication.
Exact NMC codes and competency levels must be verified against the current institutional curriculum ledger. The educational endpoint is safe examination, prevention of avoidable injury, rational symptom treatment and timely referral.
Key Exam Pearls for NEET PG
Sensory neuropathy is a syndrome: burning, tingling, numbness, loss of vibration or sensory ataxia require a pattern and cause assessment. Distal symmetric stocking symptoms are common in diabetes but do not prove diabetes. Ask about B12 deficiency, alcohol, renal and thyroid disease, paraprotein, HIV, toxins, chemotherapy, isoniazid, linezolid, nitrous oxide, excess pyridoxine and family history.
Examine sensation, ankle reflexes, power, gait, proprioception, autonomic signs, pulses and feet. A sensory level, brisk reflexes, motor weakness, asymmetry, rapid progression, cranial or bulbar signs, bladder dysfunction or severe ataxia suggests spinal, inflammatory or other urgent disease. Nerve-conduction studies assess large fibres; normal results do not exclude small-fibre neuropathy.
Use focused glucose or HbA1c, B12, blood count, renal, liver, thyroid and selected protein studies, adding tests by phenotype. Treat the cause and protect insensitive feet. Neuropathic-pain medicines require comorbidity, renal, interaction and falls review; no universal regimen is safe. Ulcer, infection, Charcot change, tissue threat, ascending symptoms or breathing difficulty warrants urgent escalation. In India, review diet, occupational and traditional exposures, affordability and barefoot risk.
Frequently Asked Questions
Does burning in my feet automatically mean diabetic neuropathy?
No. Diabetes is common, but burning feet can also reflect vitamin B12 deficiency, alcohol, medicines, toxins, nerve entrapment, small-fibre disease or spinal and inflammatory conditions. A clinician should confirm the pattern, examine the feet and nervous system, and use focused tests rather than assuming the cause.
Can I stop a medicine that I think is causing neuropathy?
Do not stop an essential medicine independently. Some treatments can contribute to neuropathy, but the decision depends on the indication, alternatives, timing and risk of withdrawal or untreated disease. Bring all medicines and supplements to the prescriber, including high-dose pyridoxine or unregulated nerve tonics.
What daily foot precautions are useful when sensation is reduced?
Inspect both feet and between the toes daily, wash and dry carefully, moisturise dry skin but not between toes, avoid barefoot walking and direct heat, and wear properly fitting footwear. Seek prompt assessment for a blister, crack, ulcer, redness, warmth, swelling, discharge, colour change or fever because pain may be muted.
When is numbness an emergency for a patient?
Seek urgent care for rapidly ascending numbness, new weakness, breathing or swallowing difficulty, severe imbalance, a sensory level, new bladder or bowel dysfunction, sudden one-sided symptoms, severe back pain with neurological change, or an acutely infected or discoloured foot. Do not wait for routine outpatient tests in these situations. A normal earlier test does not make a new red-flag pattern safe.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic